UCB’s pipeline technique: Specializing in immunology and neurology
Having spent the previous decade constructing its place in neurology and immunology, Belgian biopharma UCB’s pipeline technique is now targeted ...
Tag: Immunology
Argenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences
Argenx has agreed to amass Forte Biosciences for $2.2 billion, the businesses stated, in a deal supposed to develop the ...
The world's leading source for AI research, emerging technology, and the people building the future. Independent, rigorous, and always ahead.